Logos Capital is a San Francisco based venture capital firm investing in biotechnology-based startups. The company seeks to invest in in-house medical data analytics with scientific and clinical expertise to identify transformative therapies in life sciences and healthcare. It focuses on companies involved in new technologies and therapeutic approaches in molecular biology, bioinformatics, and genetic engineering, working towards our understanding of medicine and disease biology. Founded in 2019, the company has made four investments.
Timeline
Funded Companies
Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies.
ALX Oncology is a Burlingame, California-based biotechnology company working on pre-clinical stage immuno-oncology therapies.
Repare Therapeutics is a Saint-Laurent, Quebec-based company.
Associated investment funds
People
Arsani William, MD MBA
Chief Investment Officer
Ed Callaway
Chief Operating Officer
Edward Zhong, PhD
Head of Data Science
Graham Walmsley, MD PhD
General Partner
Virginia Yee
Chief Financial Officer & Chief Compliance Officer
Yanni Souroutzidis, MBA
Head of Research
Further reading
Documentaries, videos and podcasts
Companies
Logos Capital
Company attributes
Categories
Related Topics
Contributors
- 1
Niroj Manandhar
Software Engineer - 2
Edita Rexha
Economist - 3
Jed Christiansen
Special Projects & Business Development at Golden, Founder - Seed-DB. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Aime Anne Nisay
QA Engineer of web and mobile applications - 6
Henry Ogolla
Passionate about reading and writing.